✦ LIBER ✦

A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer

✍ Scribed by M. Altinbas; H. S. Coskun; O. Er; M. Ozkan; B. Eser; A. Unal; M. Cetin; S. Soyuer

Book ID: 109148500
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 131 KB
Volume: 2
Category: Article
ISSN: 1538-7933
DOI: 10.1111/j.1538-7836.2004.00871.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination of chemotherapy and recombin

Combination of chemotherapy and recombinant alpha-interferon in advanced non-small cell lung cancer: Multicentric randomized FONICAP trial report

✍ Andrea Ardizzoni; Franco Salvati; Riccardo Rosso; Paolo Bruzzi; Alessandra Rubag 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 647 KB

Background. Preclinical data suggested that alphainterferon (IFN) may potentiate chemotherapy cytotoxicity. Methods. A prospective multicentric randomized trial was initiated to assess the clinical benefit of adding This work was conducted by the Italian Lung Cancer Task Force (FONICAP), which carr

Randomized Phase II Trial of Erlotinib W

Randomized Phase II Trial of Erlotinib With and Without Entinostat in Patients With Advanced Non-Small-Cell Lung Cancer Who Progressed on Prior Chemotherapy

✍ Witta, S. E.; Jotte, R. M.; Konduri, K.; Neubauer, M. A.; Spira, A. I.; Ruxer, R 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 917 KB

Platinum-based combination chemotherapy

Platinum-based combination chemotherapy in advanced non-small cell lung cancer: A randomized phase II trial of the cancer and leukemia group B

✍ Green, Mark R. ;Kramar, Andrew ;Schilsky, Richard ;Stoopler, Marc ;Zimmer, Bonni 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 504 KB

## Abstract The Cancer and Leukemia Group B (CALGB) utilized a randomized phase II trial design to evaluate two cisplatin‐based combinations, cisplatin‐cytarabine (ara‐C) and cisplatin‐vinblastine, in 151 patients with advanced non‐small cell lung cancer. Patients entered on study had not received

A randomized controlled trial of combine

A randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathy

✍ David G. Charteris; G. William Aylward; David Wong; Carl Groenewald; Riaz H.Y. A 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Randomized Phase III Trial of Pemetrexed

Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy

✍ Hanna, N.; Shepherd, F. A.; Fossella, F. V.; Pereira, J. R.; De Marinis, F.; von 📂 Article 📅 2004 🏛 American Society of Clinical Oncology 🌐 English ⚖ 229 KB

PO-59 Low molecular weight heparin (LMWH

PO-59 Low molecular weight heparin (LMWH) versus best supportive care in cancer patients. A meta-analysis of randomized clinical trials

✍ S. Laporte; G. Meyer; H.R. B¨uller; H. Decousus; N. Moulin; M. Cucherat; P. Mism 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 53 KB